DAR No 4: Forxiga® /Edistride®. Dapagliflozin for heart failure with reduced ejection fraction (HFrEF)

Content tools

Share it

Another way to reduce the risk of mortality an admissions in HFrEF

Although there are no direct comparisons with sacubitril/valsartan, it is a more efficient option than the latter and could be placed as the third treatment step in HFrEF, added to standard therapy

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)

First name, middle initial and last name *

Email *

Current position or occupation *

Place of work *

Suggestions/Comments *